Investing Profile
Christoph Broja
Your Intro Paths to Christoph Broja
Current Investing Position
EQT Life Sciences Managing Director
Investment Range
$11.0M - $65.0M
Sweet Spot
$25.0M
Current Fund Size
€260M
Christoph Broja is on these Sector & Stage Rankings
Medical Devices (Seed)Pharmaceuticals (Seed)BioTech (Seed)Diagnostics (Seed)Pharmaceuticals (Pre-seed)Medical Devices (Pre-seed)Diagnostics (Pre-seed)Health IT (Pre-seed)Digital Health (Pre-seed)BioTech (Pre-seed)Health & Hospital Services (Pre-seed)Health IT (Seed)Digital Health (Seed)Health & Hospital Services (Seed)
Christoph Broja's Experience
Board Member Cardior Pharmaceuticals2022 - Present
Managing Director EQT Life Sciences2022 - Present
Principal Gurnet Point Capital2021 - 2022
Board Observer Innocoll Biotherapeutics2020 - 2022
Board Member Tremeau Pharmaceuticals, Inc.2019 - 2022
Sr. Associate Gurnet Point Capital2016 - 2021
Board Observer Boston Pharmaceuticals2016 - 2021
Business Partner B-FLEXION2012 - 2016
Senior Analyst Franz Haniel & Cie. GmbH2010 - 2012
Investors who invest with Christoph Broja